Vitiligo
RecruitingStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
- Disease:Vitiligo
- Substances:Ruxolitinib
France- Participants:0–17 years
- Substances:Ruxolitinib
- Sponsor:Incyte Corp.
Rare diseases
Investigational molecules
Locations
69 Rue Du Lieutenant Colonel Prudhon, 95107 Argenteuil, France
Centre Hospitalier Victor Dupouy in Argenteuil, France specialises in clinical trials of conditions such as Sepsis, Plasma cell myeloma, Pneumonia, Systemic candida, and other specialisations. This site conducts important research.
The medical center is at the forefront of hematology and oncology research, focusing on innovative treatments for various blood disorders and cancers. The center's research includes groundbreaking studies on Chronic Lymphocytic Leukemia (CLL), Peripheral T-cell Lymphoma (PTCL), and Diffuse Large B Cell Lymphoma (DLBCL).
Through clinical trials, the center is advancing the understanding of disease mechanisms and developing targeted therapies that improve patient outcomes.
Specializing in infectious diseases and critical care, the center conducts pivotal research on conditions such as sepsis and ventilator-associated pneumonia. The research aims to enhance treatment protocols and patient management strategies in intensive care settings.
By integrating advanced therapeutic approaches, the center is improving survival rates and quality of care for critically ill patients.
The center is a leader in respiratory and pulmonary medicine, with a focus on diseases such as chronic obstructive pulmonary disease (COPD) and severe asthma. Research efforts are directed towards optimizing treatment regimens and exploring novel therapeutic options.
Innovative clinical trials are paving the way for more effective management of respiratory conditions, enhancing patient quality of life.
Focusing on immunology and autoimmune disorders, the center is advancing research in conditions like immune thrombocytopenia (ITP) and polycythemia vera. The goal is to develop therapies that modulate the immune system to achieve better disease control.
Through cutting-edge research, the center is contributing to the development of personalized medicine approaches for autoimmune conditions.
The center's research in cardiology and vascular medicine includes studies on septic cardiomyopathy and thromboembolic events. The focus is on improving diagnostic and therapeutic strategies to enhance cardiovascular health.
By integrating novel research findings, the center is advancing the field of cardiovascular medicine, offering new hope for patients with complex vascular conditions.
More sites in ArgenteuilFrance
Clinical trials currently enrolling participants at this site.
France
France
France
France
France
France
France
France
France
France
France
FranceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.